ACE2 and COVID-19: The association of pain and COVID‐19 may be supported by the relationship between neurological and musculoskeletal manifestations and the expression and distribution of angiotensin‐converting enzyme 2, which was identified as a functional receptor for COVID‐19 [3, 21].